These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 1823078
1. Acute effects of clonidine and growth-hormone-releasing hormone on growth hormone secretion in patients with hyperthyroidism. Giustina A, Buffoli MG, Bussi AR, Wehrenberg WB. Horm Res; 1991; 36(5-6):192-5. PubMed ID: 1823078 [Abstract] [Full Text] [Related]
2. Effect of arginine on the GHRH-stimulated GH secretion in patients with hyperthyroidism. Giustina A, Schettino M, Bussi AR, Legati F, Licini M, Zuccato F, Wehrenberg WB. Horm Res; 1992; 38(5-6):256-9. PubMed ID: 1307747 [Abstract] [Full Text] [Related]
3. Galanin does not affect the growth hormone-releasing hormone-stimulated growth hormone secretion in patients with hyperthyroidism. Giustina A, Bussi AR, Legati F, Bossoni S, Licini M, Schettino M, Zuccato F, Wehrenberg WB. Acta Endocrinol (Copenh); 1992 Dec; 127(6):504-8. PubMed ID: 1283476 [Abstract] [Full Text] [Related]
4. The inhibitory effects of growth hormone-releasing hormone (GHRH)-antagonist on GHRH, L-dopa, and clonidine-induced GH secretion in normal subjects. Hanew K, Tanaka A, Utsumi A, Sugawara A, Abe K. J Clin Endocrinol Metab; 1996 May; 81(5):1952-5. PubMed ID: 8626863 [Abstract] [Full Text] [Related]
5. Different growth hormone (GH) response to GH-releasing peptide and GH-releasing hormone in hyperthyroidism. Ramos-Dias JC, Pimentel-Filho F, Reis AF, Lengyel AM. J Clin Endocrinol Metab; 1996 Apr; 81(4):1343-6. PubMed ID: 8636330 [Abstract] [Full Text] [Related]
6. Influence of hyperthyroidism on growth hormone secretion. Valcavi R, Dieguez C, Zini M, Muruais C, Casanueva F, Portioli I. Clin Endocrinol (Oxf); 1993 May; 38(5):515-22. PubMed ID: 8330446 [Abstract] [Full Text] [Related]
7. Acipimox potentiates growth hormone response to growth hormone-releasing hormone by decreasing serum free fatty acid levels in hyperthyroidism. Lee EJ, Kim KR, Lee HC, Cho JH, Nam MS, Nam SY, Song YD, Lim SK, Huh KB. Metabolism; 1995 Nov; 44(11):1509-12. PubMed ID: 7476342 [Abstract] [Full Text] [Related]
8. Reciprocal relationship between the level of circulating cortisol and growth hormone secretion in response to growth hormone-releasing hormone in man: studies in patients with adrenal insufficiency. Giustina A, Bresciani E, Bossoni S, Chiesa L, Misitano V, Wehrenberg WB, Veldhuis JD. J Clin Endocrinol Metab; 1994 Nov; 79(5):1266-72. PubMed ID: 7962318 [Abstract] [Full Text] [Related]
9. Comparative effect of clonidine and growth hormone (GH)-releasing hormone on GH secretion in adult patients on chronic glucocorticoid therapy. Giustina A, Buffoli MG, Bussi AR, Doga M, Girelli A, Pizzocolo G, Pozzi A, Wehrenberg WB. Horm Metab Res; 1992 May; 24(5):240-3. PubMed ID: 1398465 [Abstract] [Full Text] [Related]
10. Low circulating IGF-I levels in hyperthyroidism are associated with decreased GH response to GH-releasing hormone. Ramos-Dias JC, Yateman M, Camacho-Hübner C, Grossman A, Lengyel AM. Clin Endocrinol (Oxf); 1995 Nov; 43(5):583-9. PubMed ID: 8548943 [Abstract] [Full Text] [Related]
11. Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men. Devesa J, Arce V, Lois N, Tresguerres JA, Lima L. J Clin Endocrinol Metab; 1990 Dec; 71(6):1581-8. PubMed ID: 1977761 [Abstract] [Full Text] [Related]
12. Effects of methimazole treatment on growth hormone (GH) response to GH-releasing hormone in patients with hyperthyroidism. Giustina A, Ferrari C, Bodini C, Buffoli MG, Legati F, Schettino M, Zuccato F, Wehrenberg WB. Acta Endocrinol (Copenh); 1990 Dec; 123(6):613-8. PubMed ID: 2284886 [Abstract] [Full Text] [Related]
13. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion. Kelijman M, Frohman LA. J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420 [Abstract] [Full Text] [Related]
15. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone. Ghigo E, Imperiale E, Boffano GM, Mazza E, Bellone J, Arvat E, Procopio M, Goffi S, Barreca A, Chiabotto P. J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060 [Abstract] [Full Text] [Related]
16. Effects of exogenous growth hormone pretreatment on the pituitary growth hormone response to growth hormone-releasing hormone alone or in combination with pyridostigmine in type I diabetic patients. Giustina A, Bossoni S, Bodini C, Cimino A, Pizzocolo G, Schettino M, Wehrenberg WB. Acta Endocrinol (Copenh); 1991 Nov; 125(5):510-7. PubMed ID: 1759540 [Abstract] [Full Text] [Related]
17. Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects. Arvat E, Gianotti L, Grottoli S, Imbimbo BP, Lenaerts V, Deghenghi R, Camanni F, Ghigo E. J Clin Endocrinol Metab; 1994 Nov; 79(5):1440-3. PubMed ID: 7962341 [Abstract] [Full Text] [Related]
18. Short term continuous intravenous infusion of growth hormone (GH) inhibits GH-releasing hormone-induced GH secretion: a time-dependent effect. Rosenthal SM, Kaplan SL, Grumbach MM. J Clin Endocrinol Metab; 1989 Jun; 68(6):1101-5. PubMed ID: 2498383 [Abstract] [Full Text] [Related]
19. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men. Devesa J, Diaz MJ, Tresguerres JA, Arce V, Lima L. J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361 [Abstract] [Full Text] [Related]